CD4 and pneumocystosis: The risk of pneumocystosis was significantly higher in the former group of patients than in the latter group, with a risk ratio of 5.32 (95% CI, 1.18, 23.94; P = 0.03) after adjustment for age, sex, risk for HIV transmission, and baseline CD4 and PVL.